Lisanti Capital Growth’s NeoGenomics NEO Stock Holding History

Lisanti Capital Growth’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-212,935	Closed	-$3.45M	–	136
2023 Q4	$3.45M	Buy	+212,935	New	+$3.48M	0.81%	59
2023 Q3	–	Sell	-336,135	Closed	-$5.4M	–	157
2023 Q2	$5.4M	Sell	336,135 -192,100	-36%	-$3.17M	0.75%	56
2023 Q1	$9.2M	Buy	+528,235	New	+$7.53M	1.28%	27
2021 Q1	–	Sell	-115,748	Closed	-$6.23M	–	159
2020 Q4	$6.23M	Buy	115,748 +3,240	+3%	+$146K	0.86%	50
2020 Q3	$4.15M	Buy	+112,508	New	+$4.18M	0.77%	60
2020 Q2	–	Sell	-152,391	Closed	-$4.21M	–	137
2020 Q1	$4.21M	Buy	152,391 +111,926	+277%	+$3.35M	1.39%	23
2019 Q4	$1.18M	Buy	+40,465	New	+$964K	0.31%	93
2019 Q3	–	Sell	-130,760	Closed	-$2.87M	–	116
2019 Q2	$2.87M	Buy	+130,760	New	+$2.87M	0.93%	48

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Lisanti Capital Growth's NEO Position: Q1 2024 in Review

Lisanti Capital Growth sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 212,935 shares — an estimated $3.45M sold.

Lisanti Capital Growth first reported a position in NEO in Q2 2019 and held it in 8 quarters. The position peaked at $9.2M in Q1 2023. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

Lisanti Capital Growth reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
Lisanti Capital Growth sold 212,935 NeoGenomics shares in Q1 2024, an estimated $3.45M.
Lisanti Capital Growth first reported a position in NeoGenomics in Q2 2019 and held it in 8 quarters.
Lisanti Capital Growth's NeoGenomics position peaked at $9.2M in Q1 2023.
263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Lisanti Capital Growth's 13F filing for Q1 2024, filed 7 May 2024.